Instead, how about objectively evaluating the products in the pipeline? The chart will not tell you the future sales figures for Medidur, but an analysis of trial results to date, market size and competing products might go some way towards a good estimate. The chart will also not tell you how much Pfizer will pay in milestone and royalty payments for PSD's drug delivery technology.
Pezz
- Forums
- ASX - By Stock
- buyers looking strong
PSD
psivida limited
Instead, how about objectively evaluating the products in the...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)